Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,964 Cardiology
clinical trials

Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saratoga Springs, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sayre, PA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Scottsboro, AL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stockton, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tupelo, MS
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waterbury, CT
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waukesha, WI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
White River Junction, VT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Physiologic Assessment of Coronary Stenosis Following PCI
Status: Enrolling, Phase
Updated: 12/31/1969
AMC Amsterdam
mi
from
Amsterdam,
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Physiologic Assessment of Coronary Stenosis Following PCI
Status: Enrolling, Phase
Updated: 12/31/1969
Wellmont CVA Heart Insitute
mi
from
Kingsport, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Physiologic Assessment of Coronary Stenosis Following PCI
Status: Enrolling, Phase
Updated: 12/31/1969
V.A. Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Status: Enrolling
Updated: 12/31/1969
AMITA Health Adventist
mi
from
LaGrange, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburg
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwestern University, Feinberg School of Medicine - Cardiology
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital Mineola
mi
from
Mineola, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Atlantic Health System Hospital Corp - Morristown Medical Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
NC Heart and Vascular (Rex Hospital)
mi
from
Raleigh, NC
Click here to add this to my saved trials
Heart Failure Clinical Trial
REDUCE LAP-HF TRIAL II
Status: Enrolling
Updated: 12/31/1969
Christ Hospital Ohio Heart and Vascular Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Stitch Closure of PFO and Septal Repair
Status: Enrolling
Updated: 12/11/2017
Inova Cardiovascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
Status: Enrolling, Phase III
Updated: 12/31/1969
Loma Linda University Health Care, Department of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
Status: Enrolling, Phase III
Updated: 12/31/1969
Bascom Palmer Eye Institute Naples
mi
from
Naples, FL
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Retina Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
Status: Enrolling, Phase III
Updated: 12/31/1969
California Eye Specialist Medical Group
mi
from
Pasadena, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
Penn State Health Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
Nebraska Heart Institute / Nebraska Heart Hospital
mi
from
Lincoln, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
FAST Therapy Trial of Fetal Tachyarrhythmia
Status: Enrolling, Phase III
Updated: 12/14/2017
MUSC Children's Hospital
mi
from
Charleston, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
FAST Therapy Trial of Fetal Tachyarrhythmia
Status: Enrolling, Phase III
Updated: 12/14/2017
Cohen Children's Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Cardiac Failure Aggravated Clinical Trial
Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiac Failure Aggravated Clinical Trial
Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Heart Sounds Registry
Status: Enrolling, Phase
Updated: 12/31/1969
West Virginia University Research
mi
from
Morgantown, WV
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Heart Sounds Registry
Status: Enrolling, Phase
Updated: 12/31/1969
MD Strategies Research Center
mi
from
National City, CA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Denver Cardiology
mi
from
Denver, CO
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Idiopathic Dilated Cardiomyopathy Clinical Trial
DCM Precision Medicine Study
Status: Enrolling
Updated: 12/31/1969
Medstar Washington Hospital Center (DC)
mi
from
Washington DC,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Indu and Raj Soin Medical Center
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Laurens
mi
from
Clinton, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Collierville
mi
from
Collierville, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lymphoma Clinic of Michigan
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Health Mooresville
mi
from
Mooresville, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Charles Health System-Redmond
mi
from
Redmond, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Summit Cancer Care-Candler
mi
from
Savannah, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Desoto
mi
from
Southhaven, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Rockwood North Cancer Treatment Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Bhadresh Nayak MD PC-Sterling Heights
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Professional Building
mi
from
Warren, MI
Click here to add this to my saved trials
Heart Failure, Congestive Clinical Trial
Multiple Cardiac Sensors for the Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
Centra Care Heart and Vascular Center
mi
from
Cold Spring, MN
Click here to add this to my saved trials
Heart Failure, Congestive Clinical Trial
Multiple Cardiac Sensors for the Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Southern California Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Utica, NY
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Cardiac Rhythm Disorder Clinical Trial
3T MRI CIED Post-Approval Study
Status: Enrolling, Phase
Updated: 5/2/2018
Clinical Research Facility
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
Status: Enrolling, Phase IV
Updated: 12/31/1969
London Health Sciences Centre
mi
from
London,
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling, Phase IV
Updated: 12/31/1969
Cardiovascular Clinic at UF Health UF
mi
from
Gainesville, FL
Click here to add this to my saved trials
CONGESTIVE HEART FAILURE Clinical Trial
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
Status: Enrolling
Updated: 1/16/2018
Brigham and Women's Hospita
mi
from
Boston, MA
Click here to add this to my saved trials
Ventricular Tachycardia Clinical Trial
Tachy Prediction Download Study
Status: Enrolling, Phase
Updated: 12/31/1969
Princess Margaret Hospital
mi
from
Hong Kong,
Click here to add this to my saved trials
Cardiac Disease Clinical Trial
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
East Carolina Heart Institute @ ECU
mi
from
Greenville, NC
Click here to add this to my saved trials
Cancer-related Venous Thromboembolism Clinical Trial
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
Status: Enrolling
Updated: 1/22/2018
Mitchell Cancer Institute
mi
from
Mobile, AL
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Opthea Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Opthea Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Opthea Investigational Site
mi
from
Melbourne, FL
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Opthea Investigational Site
mi
from
Reno, NV
Click here to add this to my saved trials
Critical Limb Ischemia Clinical Trial
Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System
Status: Enrolling
Updated: 12/31/1969
Medstart Washington Hospital Center
mi
from
Washington DC,
Click here to add this to my saved trials
Heart Failure Clinical Trial
HCV Positive Heart Donors
Status: Enrolling, Phase IV
Updated: 12/31/1969
NYU Langone Transplant Institute
mi
from
New York, NY
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Grady Memorial
mi
from
Atlanta, GA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
OU Medical Center Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Josephs Regional
mi
from
Paterson, NJ
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Good Samaritan
mi
from
San Jose, CA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Med-star Georgetown Univ.
mi
from
Washington DC,
Click here to add this to my saved trials
Heart Failure Clinical Trial
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
CentraCare Heart & Vascular Center
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Brigham and Women's Hospital/DFCI
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology
Status: Enrolling, Phase IV
Updated: 3/22/2018
Santiago Lozano-Calderon
mi
from
Boston, MA
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Without Rupture Clinical Trial
EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study
Status: Enrolling
Updated: 12/31/1969
St. Vincent Heart of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Centre
mi
from
Charlotte, NC
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Connecticut Health Network
mi
from
Danbury, CT
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
Pharmacology Research, LLC
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
The Center for Clinical Trials, Inc.
mi
from
Saraland, AL
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
Manshadi Heart Institute Inc
mi
from
Stockton, CA
Click here to add this to my saved trials